Intestinal epithelial potassium channels and CFTR chloride channels activated in ErbB tyrosine kinase inhibitor diarrhea.
暂无分享,去创建一个
[1] J. Bowen,et al. Diarrhea Induced by Small Molecule Tyrosine Kinase Inhibitors Compared With Chemotherapy: Potential Role of the Microbiome , 2020, Integrative cancer therapies.
[2] K. Barrett. Epithelial transport in digestive diseases - mice, monolayers and mechanisms: 2019 Hans Ussing Distinguished Lecture Article. , 2020, American journal of physiology. Cell physiology.
[3] Xiaowei Qi,et al. Mechanism, safety and efficacy of three tyrosine kinase inhibitors lapatinib, neratinib and pyrotinib in HER2-positive breast cancer. , 2019, American journal of cancer research.
[4] A. Verkman,et al. Inhibition of CFTR‐mediated intestinal chloride secretion as potential therapy for bile acid diarrhea , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] Yvonne E. Moussa,et al. The side effects of platinum-based chemotherapy drugs: a review for chemists. , 2018, Dalton transactions.
[6] E. Tan,et al. Management of epidermal growth factor receptor tyrosine kinase inhibitor‐related cutaneous and gastrointestinal toxicities , 2018, Asia-Pacific journal of clinical oncology.
[7] J. Bowen,et al. Dacomitinib‐induced diarrhea: Targeting chloride secretion with crofelemer , 2018, International journal of cancer.
[8] Michael A. Yamin,et al. Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease , 2017, World journal of gastroenterology.
[9] A. Verkman,et al. Benzopyrimido‐pyrrolo‐oxazine‐dione CFTR inhibitor (R)‐BPO‐27 for antisecretory therapy of diarrheas caused by bacterial enterotoxins , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] T. Möller,et al. Inhibition of the potassium channel KCa3.1 by senicapoc reverses tactile allodynia in rats with peripheral nerve injury , 2017, European journal of pharmacology.
[11] J. Bornstein,et al. Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging Treatments , 2016, Front. Pharmacol..
[12] G. Grabenbauer,et al. Management of radiation and chemotherapy related acute toxicity in gastrointestinal cancer. , 2016, Best practice & research. Clinical gastroenterology.
[13] Alan S. Verkman,et al. Secretory diarrhoea: mechanisms and emerging therapies , 2015, Nature Reviews Gastroenterology &Hepatology.
[14] J. Bowen,et al. ErbB small molecule tyrosine kinase inhibitor (TKI) induced diarrhoea: Chloride secretion as a mechanistic hypothesis. , 2015, Cancer treatment reviews.
[15] Y. Marunaka,et al. Insulin is involved in transcriptional regulation of NKCC and the CFTR Cl− channel through PI3K activation and ERK inactivation in renal epithelial cells , 2014, The Journal of Physiological Sciences.
[16] S. Verma,et al. Management of diarrhea induced by epidermal growth factor receptor tyrosine kinase inhibitors. , 2014, Current oncology.
[17] H. Gallagher,et al. Clotrimazole as a pharmaceutical: past, present and future. , 2014, Journal of applied microbiology.
[18] E. Montassier,et al. Systematic review: the role of the gut microbiota in chemotherapy‐ or radiation‐induced gastrointestinal mucositis – current evidence and potential clinical applications , 2014, Alimentary pharmacology & therapeutics.
[19] P. Srimanote,et al. Inhibition of cAMP-Activated Intestinal Chloride Secretion by Diclofenac: Cellular Mechanism and Potential Application in Cholera , 2014, PLoS neglected tropical diseases.
[20] S. Cosimo,et al. Targeted therapy-induced diarrhea: A review of the literature. , 2014, Critical reviews in oncology/hematology.
[21] T. Ma,et al. Chloride channel inhibition by a red wine extract and a synthetic small molecule prevents rotaviral secretory diarrhoea in neonatal mice , 2013, Gut.
[22] J. Fettinger,et al. ABSOLUTE CONFIGURATION AND BIOLOGICAL PROPERTIES OF ENANTIOMERS OF CFTR INHIBITOR BPO-27. , 2013, ACS medicinal chemistry letters.
[23] J. Köhler,et al. Diarrhea associated with afatinib: an oral ErbB family blocker , 2013, Expert review of anticancer therapy.
[24] J. Finnie,et al. Development of a rat model of oral small molecule receptor tyrosine kinase inhibitor-induced diarrhea , 2012, Cancer biology & therapy.
[25] R. Frizzell,et al. Physiology of epithelial chloride and fluid secretion. , 2012, Cold Spring Harbor perspectives in medicine.
[26] A. Verkman,et al. Potent, metabolically stable benzopyrimido-pyrrolo-oxazine-dione (BPO) CFTR inhibitors for polycystic kidney disease. , 2011, Journal of medicinal chemistry.
[27] W. Voigt,et al. Review: Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management , 2010, Therapeutic advances in medical oncology.
[28] A S Verkman,et al. Crofelemer, an Antisecretory Antidiarrheal Proanthocyanidin Oligomer Extracted from Croton lechleri, Targets Two Distinct Intestinal Chloride Channels , 2010, Molecular Pharmacology.
[29] T. Satoh,et al. Effects of imidazole antimycotics on the liver microsomal cytochrome P450 isoforms in rats: comparison ofin vitro andex vivo studies , 2000, European Journal of Drug Metabolism and Pharmacokinetics.
[30] K. Ataga,et al. Senicapoc (ICA-17043): a potential therapy for the prevention and treatment of hemolysis-associated complications in sickle cell anemia , 2009 .
[31] K. Barrett,et al. Decoding epithelial signals: critical role for the epidermal growth factor receptor in controlling intestinal transport function , 2009, Acta physiologica.
[32] R. Warth,et al. Physiology and pathophysiology of potassium channels in gastrointestinal epithelia. , 2008, Physiological reviews.
[33] M. S. Katz,et al. Distinct pathways of ERK activation by the muscarinic agonists pilocarpine and carbachol in a human salivary cell line. , 2008, American journal of physiology. Cell physiology.
[34] K. Ataga,et al. Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia. , 2008, Blood.
[35] B. Ramakrishna,et al. Differential regulation of cholera toxin-inhibited Na-H exchange isoforms by butyrate in rat ileum. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[36] J. E. Matos,et al. Role of cholinergic‐activated KCa1.1 (BK), KCa3.1 (SK4) and KV7.1 (KCNQ1) channels in mouse colonic Cl− secretion , 2007, Acta physiologica.
[37] K. Ataga,et al. Dose‐Escalation Study of ICA‐17043 in Patients with Sickle Cell Disease , 2006, Pharmacotherapy.
[38] Renato Martins,et al. Erlotinib in previously treated non-small-cell lung cancer. , 2005, The New England journal of medicine.
[39] A. Caputy,et al. Inhibition of tumor growth and prolonged survival of rats with intracranial gliomas following administration of clotrimazole. , 2005, Journal of neurosurgery.
[40] P. Dudeja,et al. Differential regulation of Na+/H+ exchange isoform activities by enteropathogenic E. coli in human intestinal epithelial cells. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[41] Jennifer A. Clark,et al. Involvement of the ERK Signaling Cascade in Protein Kinase C-mediated Cell Cycle Arrest in Intestinal Epithelial Cells* , 2004, Journal of Biological Chemistry.
[42] K. Barrett,et al. Gs Protein-coupled Receptor Agonists Induce Transactivation of the Epidermal Growth Factor Receptor in T84 Cells , 2004, Journal of Biological Chemistry.
[43] A. Verkman,et al. Prevention of toxin-induced intestinal ion and fluid secretion by a small-molecule CFTR inhibitor. , 2004, Gastroenterology.
[44] D. Halm. Secretory control of basolateral membrane potassium and chloride channels in colonic crypt cells. , 2004, Advances in experimental medicine and biology.
[45] J. Stocker,et al. ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice. , 2003, Blood.
[46] M. Yokoyama,et al. Inhibitory effect of clotrimazole on angiogenesis associated with bladder epithelium proliferation in rats , 2003, International journal of urology : official journal of the Japanese Urological Association.
[47] Hong Yang,et al. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. , 2002, The Journal of clinical investigation.
[48] R. Coffey,et al. Transactivation of the Epidermal Growth Factor Receptor in Colonic Epithelial Cells by Carbachol Requires Extracellular Release of Transforming Growth Factor-α* , 2002, The Journal of Biological Chemistry.
[49] L. Thim,et al. Protein Kinase C and ERK Activation Are Required for TFF- peptide-stimulated Bronchial Epithelial Cell Migration and Tumor Necrosis Factor-α-induced Interleukin-6 (IL-6) and IL-8 Secretion* , 2002, The Journal of Biological Chemistry.
[50] A. K. Singh,et al. Benzimidazolone activators of chloride secretion: potential therapeutics for cystic fibrosis and chronic obstructive pulmonary disease. , 2001, The Journal of pharmacology and experimental therapeutics.
[51] K. Barrett,et al. A Role for Protein Kinase Cε in the Inhibitory Effect of Epidermal Growth Factor on Calcium-stimulated Chloride Secretion in Human Colonic Epithelial Cells* , 2000, The Journal of Biological Chemistry.
[52] A. Benson,et al. Management of cancer treatment-related diarrhea. Issues and therapeutic strategies. , 2000, Journal of pain and symptom management.
[53] L. Svensson,et al. Role of the enteric nervous system in the fluid and electrolyte secretion of rotavirus diarrhea. , 2000, Science.
[54] K. Barrett,et al. Chloride secretion by the intestinal epithelium: molecular basis and regulatory aspects. , 2000, Annual review of physiology.
[55] K. Barrett,et al. A role for protein kinase cepsilon in the inhibitory effect of epidermal growth factor on calcium-stimulated chloride secretion in human colonic epithelial cells. , 2000, Journal of Biological Chemistry.
[56] K. Barrett,et al. ErbB2 and ErbB3 Receptors Mediate Inhibition of Calcium-dependent Chloride Secretion in Colonic Epithelial Cells* , 1999, The Journal of Biological Chemistry.
[57] P. Thorn,et al. Activation of Ca2+- and cAMP-sensitive K+ channels in murine colonic epithelia by 1-ethyl-2-benzimidazolone. , 1999, American journal of physiology. Cell physiology.
[58] K. Barrett,et al. Carbachol Stimulates Transactivation of Epidermal Growth Factor Receptor and Mitogen-activated Protein Kinase in T84Cells , 1998, The Journal of Biological Chemistry.
[59] K. Barrett,et al. Carbachol stimulates transactivation of epidermal growth factor receptor and mitogen-activated protein kinase in T84 cells. Implications for carbachol-stimulated chloride secretion. , 1998, The Journal of biological chemistry.
[60] S. Alper,et al. The antifungal antibiotic, clotrimazole, inhibits chloride secretion by human intestinal T84 cells via blockade of distinct basolateral K+ conductances. Demonstration of efficacy in intact rabbit colon and in an in vivo mouse model of cholera. , 1997, The Journal of clinical investigation.
[61] D. Vandorpe,et al. The Antifungal Imidazole Clotrimazole and its Major In Vivo Metabolite are Potent Blockers of the Calcium-Activated Potassium Channel in Murine Erythroleukemia Cells , 1997, The Journal of Membrane Biology.
[62] Lianwei Jiang,et al. The antifungal antibiotic, clotrimazole, inhibits Cl- secretion by polarized monolayers of human colonic epithelial cells. , 1996, The Journal of clinical investigation.
[63] K. Barrett,et al. Epidermal growth factor inhibits Ca(2+)-dependent Cl- transport in T84 human colonic epithelial cells. , 1996, The American journal of physiology.
[64] O. Platt,et al. Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease. , 1996, The Journal of clinical investigation.
[65] J. Kaper,et al. Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. , 1996, Microbiological reviews.
[66] O. Platt,et al. HPLC measurement, blood distribution, and pharmacokinetics of oral clotrimazole, potentially useful antisickling agent. , 1995, Clinical chemistry.
[67] F.J. Sauvage,et al. Activation of intestinal CFTR Cl‐ channel by heat‐stable enterotoxin and guanylin via cAMP‐dependent protein kinase. , 1994, EMBO Journal.
[68] Marino Aa,et al. Potassium channels in epithelial cells. , 1993 .
[69] Andrew A. Marino,et al. Potassium channels in epithelial cells. , 1993, Cellular & molecular biology research.